Skip to main content

Home/ Educational Technology Curriculum and Instruction/ Group items matching "Pompe" in title, tags, annotations or url

Group items matching
in title, tags, annotations or url

Sort By: Relevance | Date Filter: All | Bookmarks | Topics Simple Middle
ajinkyak

Pompe Disease Therapeutic Market by Commercial Sector, Analysis and Outlook to 2027 - PRnews Leader - 0 views

prnewsleader.com/...r-analysis-and-outlook-to-2027

Pompe disease metabolic disorder alpha-glucosidase enzyme therapeutic treatment

shared by ajinkyak on 25 Jan 21 - No Cached
  • ajinkyak on 25 Jan 21
     
    Pompe disease or also referred to as Glycogen storage disease type II is an autosomal recessive metabolic disorder that damages nerve cells and muscles throughout the body.
ajinkyak

As key marketer Sanofi reports clinically relevant changes for its Phase III trial of Enzyme Replacement Therapy, the Pompe Disease Therapeutic market is expected to grow significantly - 0 views

digitalinsightscmi-blog.blogspot.com/...y-marketer-sanofi-reports.html

Pompe Disease Therapeutic market trends size

shared by ajinkyak on 18 May 21 - No Cached
  • ajinkyak on 18 May 21
     
    Pompe disease or additionally alluded to as Glycogen stockpiling sickness type II is an autosomal passive metabolic problem that harms nerve cells and muscles all through the body. It is normally caused because of the aggregation of glycogen in the lysosome, inferable from insufficiency of the lysosomal corrosive alpha-glucosidase chemical.
1 - 2 of 2
Showing 20▼ items per page